BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

VelaVigo Bio Signs $440M Global Licensing Deal with Ollin Biosciences for First-in-Class Bispecific Antibody VBS-102

VelaVigo Bio, the U.S. subsidiary of VelaVigo Cayman Limited (VelaVigo), a biotech company with a robust discovery and development platform of multi-specif...

April 18, 2025 | News

Thermo Fisher Opens Advanced Therapies Collaboration Center in Carlsbad to Accelerate Cell Therapy Development

Thermo Fisher Scientific Inc., the world leader in serving science, announced the grand opening of its Advanced Therapies Collaboration Center (ATxCC...

April 18, 2025 | News

Rege Nephro Acquires Tamibarotene Assets from Syros Pharmaceuticals to Advance ADPKD Program

Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired Tami...

April 16, 2025 | News

Thermo Fisher Launches 5L DynaDrive Single-Use Bioreactor to Accelerate Scalable Bioprocessing

First-of-its-kind bench scale bioreactor enabling productivity, scalability and efficiency supporting reduced environmental impact Thermo Fisher Scientifi...

April 15, 2025 | News

GPC-100, a CXCR4 Inhibitor, Moves Toward AML Trials Following Promising Preclinical and Phase 1 Data; Phase 2 in Multiple Myeloma Ongoing

Exicure, Inc. shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. (“Exicure”) is planning f...

April 14, 2025 | News

Patent Wars and Patient Lives: Inside Roche vs Natco Over Risdiplam

In a courtroom packed with legal heavyweights, global pharmaceutical giant F. Hoffmann-La Roche AG faced off against Indian generic manufac...

April 14, 2025 | Analysis

Novartis Commits $23B to U.S. Expansion, Bringing 100% of Key Drug Production Onshore

Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities With new manuf...

April 11, 2025 | News

Halozyme and argenx Secure FDA Nod for VYVGART® Hytrulo Prefilled Syringe for Self-Injection

Halozyme Therapeutics, Inc. announced that argenx has received U.S. Food and Drug Administration (FDA) approval of VYVGART® Hytrulo prefilled syri...

April 11, 2025 | News

Nona Biosciences Partners with Atossa Therapeutics to Advance Next-Generation Antibody Therapies for Breast Cancer

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), ranging from target validation and antibody ...

April 11, 2025 | News

Logistics4Pharma Expands Customs Services to Strengthen Global Pharma Supply Chains

Logistics4Pharma, a Frankfurt-based GDP-certified pharma logistics provider, has expanded its service portfolio. In addition to Temporary Storage und...

April 09, 2025 | News

I Peace Brings Personalized iPS Cell and Longevity Therapies to the U.S.

– I Peace, Inc., a global pioneer in induced pluripotent stem cell (iPSC) technology, proudly announces the U.S. launch of its groundbreaking persona...

April 07, 2025 | News

Bayer Seeks U.S. Supreme Court Intervention in Missouri Roundup™ Case Amid Nationwide Labeling Disputes

Bayer – through its indirect subsidiary Monsanto – filed its petition for a writ of certiorari with the U.S. Supreme Court in the&nbs...

April 07, 2025 | News

Daiichi Sankyo and AstraZeneca’s ENHERTU Approved in EU for Earlier Treatment of HER2 Low and Ultralow Breast Cancer

Based on DESTINY-Breast06 phase 3 trial results which showed ENHERTU demonstrated superiority versus chemotherapy with a median progression-free surviv...

April 04, 2025 | News

Cytiva Introduces MabSelect SuRe 70 & PrismA X to Boost Cost-Efficient mAb Purification

MabSelect SuRe 70 and MabSelect PrismA X resins to set new standards in affordability and productivity Cytiva's expanded resin portfolio wil...

April 04, 2025 | News

Stay Connected